Costs and cost-effectiveness of new technologies in cancer.

Cancer treatment and research

Volumn 97, Issue , 1998, Pages 25-36

  Waters, T M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

COST BENEFIT ANALYSIS; ECONOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; NEOPLASM; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COST-BENEFIT ANALYSIS; DATA COLLECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV SEROPOSITIVITY; HUMANS; NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

EID: 0031607292     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-0-585-30498-4_3     Document Type: Review

References (16)